Professor Gregory was not only enthusiastic about his career, but also personally introduced senior executives of Glaxo History Co., Ltd. to Chen Shuqin.

No one knew the process of the tripartite negotiations, but in the end several agreements were reached.

1. Pumpkin Vine Pharmaceutical Company officially invited Professor Gregory to officially become a partner in Helicobacter pylori research.

Professor Gregory himself is the spokesperson for GlaxoScience. His official joining means the participation of GlaxoScience. We are now a family and a community of interests.

2. Pumpkin Vine Pharmaceutical Company officially authorized GlaxoSchiko to obtain patents for three drugs: omeprazole, clarithromycin and bismuth potassium citrate. It can be produced by itself. The business scope is the entire Europe and Africa, and the patent authorization fee is 4.2% of sales.

Don’t underestimate the 0.8% concession, which involves tens of millions of dollars, or even hundreds of millions of dollars in the future. This makes the senior executives of GlaxoScience very satisfied.

Capitalists only have money in their eyes, and only money can impress them.

3. GlaxoSchizophrenia supports Helicobacter pylori research to apply for the Nobel Prize in Medicine in the future and is willing to do our best to help with public relations (PR fees are provided by Pumpkin Vine.)

4. GlaxoShiko is preparing to sell Xiangjiang Margrit Hospital to Pumpkin Vines Xiangjiang Company and will no longer retain its shares.

The acquisition of the hospital was an unexpected gain, and Chen Shuqin seized the opportunity.

In the next few days, Chen Shuqin's negotiations with two other international pharmaceutical giants were very successful.

Because this itself is an unequal negotiation, Xiangjiang Pumpkin Vine Pharmaceutical Company has a lot of room for operation.

And from the perspective of commercial negotiations, we have introduced multiple pharmaceutical companies to form a long competition, allowing the negotiations to be completely completed at the fastest speed.

In order to avoid too many patented pharmaceutical companies, causing unnecessary competition and trouble, and to allow pharmaceutical companies that have obtained patents to taste the sweetness of monopoly, this time the patent of Pumpkin Vines was granted to only three pharmaceutical companies.

Mine Guohuiduan Pharmaceutical obtained patents in the Americas, GlaxoSchizko obtained patents in Europe and Africa, and Japan Takeda Pharmaceutical obtained patents in Asia and Oceania (excluding mainland and Hong Kong).

Patent fees are charged at 4.6% of sales, rather than 5% of the previous ones (the agreement with GlaxoSchizko is confidential)

A little concession was made here, but there were also gains. Pumpkin Vine signed a strategic cooperation agreement with these three world's largest pharmaceutical companies.

In the future, Pumpkin Vine Pharmaceutical Company will have any new drugs? Under the same conditions, the patent will be authorized to Huiduan Pharmaceutical, GlaxoShiji, and Takeda Pharmaceutical.

At the same time, the three pharmaceutical companies guarantee that when the new medicines of Pumpkin Vines are to be exported, they will handle the public relations of the National Drug Administration.

And will fully support the Nobel Prize Public Relations for the Helicobacter pylori project.

This is beneficial to everyone. As long as this topic wins the Nobel Prize, the patent will be more valuable, and the public is more willing to believe in this four-link therapy that won the Nobel Prize.

With the support of these three giants, the Nobel Prize is no longer a problem. I dare not say 100%, but it is almost a 99% success rate.

After ending a series of business negotiations in London, Chen Shuqin returned to China and flew directly from England to the mainland.

There was also a huge delegation following Chen Shuqin to the mainland.

This includes Mr. Gregory, director of the Department of Gastroenterology at Wellington Hospital and professor at Oxford University School of Medicine, and Mr. Chris Grelin, deputy general manager of GlaxoShandong.

Professor Gregory came for the three-party laboratories of China, Britain and Hong Kong. This is a major event that he and Chen Chun jointly attacked the Nobel Prize in Medicine, and he must personally check it.

The arrival of GlaxoShiko is mainly for the sale of the Magrit Hospital in Hong Kong.

If you want to say that Chen Xia’s protagonist’s halo is really lucky.

It happened to be 1984, when China and Britain signed an agreement on the return of Hong Kong. People were unstable, and what followed was the stock market plummeting, the real estate market collapsed, and the economy began to enter a state of crisis.

The English are very smart. Since Hong Kong is no longer their territory in the future, the places where they should be troubled will be troubled, and the opportunities for arbitrage will be arbitrage.

What is reflected in the market is not only the withdrawal of a large amount of funds from the stock market and the real estate market, but also the British capital began to retreat on a large scale. After all, they are not confident that Xiangjiang has returned to China.

It happened that as a member of British capital, senior executives of GlaxoShiko are also preparing to liquidate and evacuate Xiangjiang's assets, including Margrit Hospital.

Founded in 1937, Margrit Hospital is located in the southwest of Hong Kong Island. It is a private comprehensive hospital. It ranks third among all hospitals in Hong Kong. It has 1,000 beds and a complete range of departments.

But this hospital is awkward and ranked third, neither up nor down.

In Xiangjiang, it is not a top hospital and cannot attract too many top wealthy people to seek medical treatment, so they will not receive donations from these rich people.

The high fees charged by private hospitals mean that most Xiangjiang citizens will not come to Margrit Hospital for treatment.

So after so many years of operation, the hospital has not lost money, but it cannot generate profits.

For capitalists, not being able to make money is the original sin, it is a waste of money, it is a pity to eat it.

However, due to political needs, GlaxoShiko has maintained the normal operation of Margrit Hospital, and of course it has no further investment. It has always been a third child, without any desires.

Isn't this the British capital withdrawal now? GlaxoShiko Company is also going to follow, so it intends to sell Margrit Hospital and has also contacted some Xiangjiang Huazu.

However, the hospital is a public welfare nature and will not generate large profits. Moreover, the hospital's scientific research funds and equipment renewal require large amounts of funds.

Those rich people in Xiangjiang are not very interested. For those vampires, the real estate industry is a huge profit. Who is interested in managing people's livelihood without any effort?

The key is that the land of Margrit Hospital is medical land and cannot be converted for commercial and residential purposes according to the law. So what is the use of buying a hospital?

In this way, the hospital has never found a buyer.

Now it happened that Pumpkin Vine Pharmaceutical Company had an idea, and GlaxoShiko was able to get rid of the blame, and the two sides immediately hit it off.

But after all, this is a large hospital, and it is said to be sold to you, and many conditions must be negotiated, not just the transfer fee.

Since GlaxoSchiko decided to form an alliance with Pumpkin Vine, of course she needs to gain the favor of Chen Xia, the boss behind the scenes. Also, see if there is any other place to cooperate with?
Chapter completed!